Science

Guidelines for diagnosis and therapy of ANCA-associated vasculitides

/

In December 2017, the German Society for Rheumatology (DGRh) published their first guideline for the diagnosis and treatment of ANCA-associated forms of vasculitis (AAV) [1]. The AAV encompass granulomatosis with polyangiitis (GPA, formerly Wegener’s granulomatosis), microscopic polyangiitis (MPA) and eosinophilic granulomatosis with polyangiitis (EGPA, formerly Churg-Strauss syndrome), which all occur with autoantibodies against cytoplasmic antigens […]

Products

Cross-reactive anti-CCD antibodies can hinder allergy diagnostics

/

In persons with type I allergies, the immune system forms IgE antibodies at first contact with a usually harmless substance (allergen) from the environment, e.g. against certain proteins in pollen, animal hair or food. At every further contact, the binding between the antibodies and the allergen can cause diverse immune reactions, including swelling of mucous

Science

Uromodulin – a protein with many clinical implications

/

Uromodulin, which was first described as Tamm-Horsfall protein in 1950, is an important biomarker in nephrology. The protein is exclusively expressed in the kidney and is mostly secreted into the renal tubules. A small amount also ends up in the blood circulation. Both uromodulin concentration in urine as well as in serum are used as

Events

A visit at the Workshop on Biomarkers for Neurodegeneration

/

A good jog to start the day and wake the brain up! That was the first item on the agenda of the workshop on neurodegenerative diseases, organised by Dr Britta Brix for the colleagues from the international EUROIMMUN subsidiaries. The company has by now a large number of test systems for the determination of biomarkers

Employees, People

Interview with Dr Wolfgang Schlumberger: “Our solutions are as individual as our customers”

/

When Dr Wolfgang Schlumberger, Vice Chairman of the Executive Board at EUROIMMUN AG visited the largest meeting for laboratory medicine in Poland, the colleagues from the EUROIMMUN subsidiary in Poland used the opportunity to ask him some questions about the in-vitro diagnostics market, about EUROIMMUN and about his beginnings in the company. “Our solutions are

Scroll to Top